Paul-Ehrlich-Institut Collected and Reported The Blood Supply Situation for 2024
Paul-Ehrlich-Institut shared a post on LinkedIn:
“Blood, blood products and stem cell preparations are indispensable for the treatment of many diseases and injuries. Their production relies on the help of numerous voluntary donors. It is therefore important to monitor the supply situation for blood and blood products in Germany so that measures can be taken to promote blood and plasma donation when shortages become apparent.
Every year, the Paul-Ehrlich-Institut collects data from donation centres, manufacturers and healthcare facilities in order to obtain a comprehensive overview of the supply of blood, blood products and stem cell preparations in Germany. The supply situation for 2024 is presented in the report that has now been published.
Read the full report here.”
Follow the latest in Hemostasis Today.
-
Feb 20, 2026, 17:35Wolfgang Miesbach: Plasma FIX Is Only Part of the Story In Haemophilia B
-
Feb 20, 2026, 17:27Sheharyar Raza: Examining Guideline Discordance in Evidence-Based Apheresis Recommendations
-
Feb 20, 2026, 17:23Barbara Mora: Newly Discovered EPO Gene Intronic Variant as a Cause of Congenital Erythrocytosis
-
Feb 20, 2026, 16:48Miguel Brito: Newborn Screening and Challenges in Follow-Up Care for Sickle Cell Disease in Angola
-
Feb 20, 2026, 16:41Uche Kennedy: Hemophilia Care Needs Systems Reform, Not Short-Term Fixes
-
Feb 20, 2026, 16:33Sonal Sonu: Real Clinical Maturity is Knowing When to Stop
-
Feb 20, 2026, 16:27Clear Recommendations for Daily Management and Family Support in Hemophilia A – WFH
-
Feb 20, 2026, 15:56Alan Nurden: Highlighting the Role of Activated Platelets in Heart and Kidney Complications of Diabetes
-
Feb 20, 2026, 15:51Domenico Girelli: Continuing Commitment to Rare Disease Research